Medical AI Alliance
← Company Index
Biotech & Drug DiscoveryKOSPI 033270287 approvals129 trials

KOREA UNITED PHARM INC

Official website

Prescription drugmaker specializing in incrementally modified drugs such as Cilostan CR, exporting to about 40 countries.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1987 and listed on KOSPI in 2007, the company is a prescription drug manufacturer specializing in incrementally modified drugs (IMDs). It produces about 200 products including the IMDs Cilostan CR, Atmax Combi Gel, and Gastin CR, manufacturing solid dosage forms, injectables, anticancer drugs, and inhalers across its Sejong 1 and 2 plants. In 2025 it recorded revenue of KRW 288.8 billion with a 17% operating margin, exported 10% of sales to about 40 countries, and invested over 12% of revenue in R&D, resulting in a total of 18 IMDs and reformulated products launched to date.

Products & technology

  • Cilostan CRIncrementally modified drug
  • Atmax Combi GelIncrementally modified drug
  • Gastin CRIncrementally modified drug

Regulatory approvals

data.go.kr

287 Korean MFDS drug approvals · 1976–2026

  • MFDS drugEDOBAN Tab. 60mg2026-08-05
    Drug · Prescription · Approval202602261
  • MFDS drugSERETEROL ACTIVAIR Inhalation Powder 250/50(Fluticasone Propionate, Salmeterol)2026-06-02
    Drug · Prescription · Approval202601599
  • MFDS drugFENODUO Cap.2026-05-28
    Drug · Prescription · Approval202601552
  • MFDS drugAzafrine Tab. 12.5mg2026-02-13
    Drug · Prescription · Approval202600436
  • MFDS drugAlkafen Speed Soft Capsule2026-02-03
    Drug · OTC · Approval202600296
  • MFDS drugAlkafen Nasal A Soft Capsule2026-01-15
    Drug · OTC · Notification202600145
  • MFDS drugATMEG CombiGel softcaps. 20/1000mg2026-01-06
    Drug · Prescription · Approval202600039
  • MFDS drugCilo Duo CR Tab. 200/20mg2025-08-27
    Drug · Prescription · Approval202502256
  • MFDS drugCilo Duo CR Tab. 200/10mg2025-08-27
    Drug · Prescription · Approval202502257
  • MFDS drugPITARIC Cap.2025-05-29
    Drug · Prescription · Approval202501335
  • MFDS drugGinkona Tab.2024-10-16
    Drug · OTC · Notification202402444
  • MFDS drugROSUMEG CombiGel Soft Cap. 10/1000mg(Rosuvastatin, Omega-3-acid ester 90)2024-04-25
    Drug · Prescription · Approval202400974
Show 68 more
  • MFDS drugDAUNOCIN Inj. 20mg2024-03-25
    Drug · Prescription · Approval202400632
  • MFDS drugNewjenta CR Tab.2024-03-05
    Drug · Prescription · Approval202400470
  • MFDS drugIrino injection2024-01-11
    Drug · Prescription · Approval202400089
  • MFDS drugthymofle2024-01-04
    Drug · Prescription · Approval202400027
  • MFDS drugROSUMEG CombiGel Soft Cap.2023-12-19
    Drug · Prescription · Approval202303366
  • MFDS drugGADOVA2023-11-09
    Drug · Prescription · Approval202303106
  • MFDS drugRABEMINI Tab.2023-10-18
    Drug · Prescription · Approval202302938
  • MFDS drugVIATIN M Tab.2023-06-30
    Drug · Prescription · Approval202302026
  • MFDS drugATMEG CombiGel softcaps. 2.5/1000mg2022-12-01
    Drug · Prescription · Approval202204318
  • MFDS drugDapaU Tab.2022-08-19
    Drug · Prescription · Approval202203322
  • MFDS drugATMEG CombiGel softcaps. 5/1000mg2022-07-21
    Drug · Prescription · Approval202203038
  • MFDS drugRABEDUO Tab2022-01-28
    Drug · Prescription · Approval202200514
  • MFDS drugHealus Tab. 50mg2022-01-10
    Drug · Prescription · Approval202200168
  • MFDS drugHealusmet Tabs. 50/500 mg2021-10-18
    Drug · Prescription · Approval202106959
  • MFDS drugCorobin Activair2021-07-13
    Drug · Prescription · Approval202105306
  • MFDS drugKorea United Vancomycine Hydrochloride Inj. 1g2021-01-29
    Drug · Prescription · Notification202100940
  • MFDS drugAlkafen Speed Soft CapsuleRevoked2021-01-25
    Drug · OTC · Approval202100762
  • MFDS drugATMEG CombiGel softcaps.2021-01-21
    Drug · Prescription · Approval202100664
  • MFDS drugViatin Tabs. 50mg2021-01-08
    Drug · Prescription · Approval202100172
  • MFDS drugEZETOVA Tab 10/10 mg2021-01-08
    Drug · Prescription · Approval202100182
  • MFDS drugEZETOVA Tab 10/40 mgRevoked2021-01-08
    Drug · Prescription · Approval202100180
  • MFDS drugEZETOVA Tab 10/20 mgRevoked2021-01-08
    Drug · Prescription · Approval202100181
  • MFDS drugAlkafen Nasal A Soft CapsuleRevoked2020-12-14
    Drug · OTC · Notification202008743
  • MFDS drugCered Inj.Revoked2020-10-13
    Drug · Prescription · Notification202006966
  • MFDS drugVancozin Cap. 125mg2020-08-27
    Drug · Prescription · Approval202006034
  • MFDS drugResoid Tab. 1mgRevoked2020-08-18
    Drug · Prescription · Approval202005840
  • MFDS drugResoid Tab. 2mgRevoked2020-08-18
    Drug · Prescription · Approval202005841
  • MFDS drugKorea United Dactinomycin Injection2020-07-22
    Drug · Prescription · Approval202005256
  • MFDS drugUsosan Tab. 100mgRevoked2020-07-10
    Drug · OTC · Notification202005007
  • MFDS drugThiodan Tab. 32.5mg2020-07-02
    Drug · Prescription · Approval202004829
  • MFDS drugGlicetil Tab.2020-04-28
    Drug · Prescription · Approval202003156
  • MFDS drugPrephentin Tab. 75mg2020-04-27
    Drug · Prescription · Approval202003059
  • MFDS drugTamstro SR Tab. 0.4mg2020-04-17
    Drug · Prescription · Approval202002725
  • MFDS drugPrephentin Tab. 150mg2020-04-10
    Drug · Prescription · Approval202002552
  • MFDS drugDoneptin Tab. 10mg2020-04-03
    Drug · Prescription · Approval202002345
  • MFDS drugDoneptin Tab. 5mg2020-04-03
    Drug · Prescription · Approval202002346
  • MFDS drugLomin Comp Syrup.2020-03-13
    Drug · Prescription · Approval202001761
  • MFDS drugFegout Tab. 40mg2020-01-31
    Drug · Prescription · Approval202000520
  • MFDS drugEldotein Tabs.2020-01-13
    Drug · OTC · Notification202000200
  • MFDS drugViatin Tab. 100mg2020-01-03
    Drug · Prescription · Approval202000060
  • MFDS drugKorea United Azathioprine Tab. 50mg2019-09-26
    Drug · Prescription · Approval201906852
  • MFDS drugFenorics EH Tab.2019-06-28
    Drug · Prescription · Approval201904452
  • MFDS drugPiosk Tab. 15mg2019-06-27
    Drug · Prescription · Approval201904418
  • MFDS drugOMETHYL CUTIELET(Omega-3-acid ethylesters 90)2019-04-15
    Drug · Prescription · Approval201902306
  • MFDS drugGlicetil Syrup2019-03-29
    Drug · Prescription · Approval201901960
  • MFDS drugTiglor Tab. 90mg2019-03-15
    Drug · Prescription · Approval201901595
  • MFDS drugKalomin Syrup2019-02-27
    Drug · OTC · Approval201901219
  • MFDS drugTiglor Tab. 60mg2019-02-21
    Drug · Prescription · Approval201901067
  • MFDS drugKalomin S Tab.2019-01-09
    Drug · Prescription · Notification201900093
  • MFDS drugTamiselva Cap. 45mgRevoked2018-04-05
    Drug · Prescription · Approval201801499
  • MFDS drugTamiselva Cap. 30mgRevoked2018-04-05
    Drug · Prescription · Approval201801500
  • MFDS drugUnitib Tab. 100mg2018-03-30
    Drug · Prescription · Approval201801437
  • MFDS drugUnigrel CR Tab.2018-02-23
    Drug · Prescription · Approval201800910
  • MFDS drugClavixin Duo Cap. 75/75mg2018-02-08
    Drug · Prescription · Approval201800764
  • MFDS drugAzafrine Tab. 25mg2017-12-21
    Drug · Prescription · Approval201708459
  • MFDS drugFovead Tab.2017-12-21
    Drug · Prescription · Approval201708476
  • MFDS drugCorbi C Inj.Revoked2017-12-13
    Drug · Prescription · Notification201708355
  • MFDS drugDexima Tab.2017-11-30
    Drug · Prescription · Approval201708195
  • MFDS drugFegout Tab. 80mg2017-10-27
    Drug · Prescription · Approval201707620
  • MFDS drugPlatinox Inj.2017-08-14
    Drug · Prescription · Approval201706577
  • MFDS drugTezomin Inj. 2.5mg2017-06-20
    Drug · Prescription · Approval201704494
  • MFDS drugLevotics CR Tab.2017-04-12
    Drug · Prescription · Approval201701832
  • MFDS drugTeramopine Tab. 80/5mg2017-03-31
    Drug · Prescription · Approval201701558
  • MFDS drugTeramopine Tab. 40/5mg2017-01-20
    Drug · Prescription · Approval201700389
  • MFDS drugCilostan CR Tab. 100mg2016-12-30
    Drug · Prescription · Approval201607419
  • MFDS drugErlotib Tab. 100mg2016-10-28
    Drug · Prescription · Approval201606331
  • MFDS drugGastiin CR Tab.2016-06-30
    Drug · Prescription · Approval201604113
  • MFDS drugSimpex Duo Tab. 10/10mg2016-03-31
    Drug · Prescription · Approval201601736

Showing the 80 most recent of 287 records.

Clinical trials

data.go.kr

129 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 64 · Phase 1 49 · Phase 3 13 · Phase 2 2 · Phase 4 1)

  • Phase 1UIC202603, UIC2026042026-07-14

    2 trial sites

  • Phase 1UI0592026-06-23

    1 trial site

  • Phase 1UIC202601, UIC2026022026-05-04

    2 trial sites

  • BioequivalenceUG25022026-03-05

    1 trial site

  • BioequivalenceUG25022026-03-03

    1 trial site

  • Phase 3UI1222026-01-20

    20 trial sites

  • Phase 1UIC202502, UIC2025052025-07-30

    2 trial sites

  • Phase 1UG22012025-06-30

    2 trial sites

  • Phase 1UI0872025-06-19

    2 trial sites

  • Phase 1UIC202007, UIC202306, UIC2023072025-06-19

    1 trial site

  • BioequivalenceUG22022025-06-10

    2 trial sites

  • Phase 1UI1112025-03-27

    2 trial sites

Show 68 more
  • Phase 1UI0282025-02-19

    2 trial sites

  • Phase 1UI1112024-12-09

    2 trial sites

  • BioequivalenceUI0092024-10-09

    2 trial sites

  • BioequivalenceUG24012024-10-09

    2 trial sites

  • Phase 1UI0592024-08-08

    1 trial site

  • Phase 1UI1002024-07-16

    2 trial sites

  • Phase 3UI0282024-05-07

    17 trial sites

  • Phase 1UIC202007, UIC202306, UIC2023072024-04-09

    1 trial site

  • BioequivalenceUG22022024-03-29

    2 trial sites

  • Phase 1UIC202304, UIC2023052023-09-18

    2 trial sites

  • Phase 1UI0592023-08-07

    1 trial site

  • BioequivalenceUI0092023-06-02

    2 trial sites

  • Phase 1UI0682023-02-01

    2 trial sites

  • Phase 1UI0682023-01-25

    2 trial sites

  • Phase 3UIC202007, UIC202306, UIC2023072023-01-11

    25 trial sites

  • Bioequivalence우소산정200mg(우르소데옥시콜산)2022-12-14

    2 trial sites

  • Phase 1UI0612022-11-11

    2 trial sites

  • Phase 1UIC202007, UIC202306, UIC2023072022-10-31

    1 trial site

  • Bioequivalence로수맥콤비젤연질캡슐2022-06-14

    2 trial sites

  • Phase 1UI0402022-06-09

    2 trial sites

  • Phase 1UI0162022-05-10

    2 trial sites

  • Phase 3UI0742022-03-04

    6 trial sites

  • Phase 1UIC202007, UIC202306, UIC2023072022-01-14

    1 trial site

  • Phase 1UI0612022-01-11

    2 trial sites

  • Phase 1UI0182021-08-19

    2 trial sites

  • Bioequivalence에소놀캡슐40mg(에스오메프라졸마그네슘이수화물)2021-06-14

    2 trial sites

  • Phase 2UI0302021-05-28

    4 trial sites

  • BioequivalenceUI0092021-05-25

    2 trial sites

  • Phase 1UI0612021-04-28

    2 trial sites

  • Bioequivalence글리진정10밀리그램2021-03-02

    2 trial sites

  • Phase 1UI058, UIC2020042021-02-03

    2 trial sites

  • Bioequivalence로수맥콤비젤연질캡슐2021-02-03

    2 trial sites

  • Phase 1UIC202007, UIC202306, UIC2023072020-12-18

    1 trial site

  • Phase 1UI0362020-07-02

    1 trial site

  • Phase 1UIC202001, UIC2020022020-07-02

    1 trial site

  • Phase 1UN042020-05-11

    1 trial site

  • Phase 3UI0632020-01-17

    8 trial sites

  • Bioequivalence에제토바정 10/20밀리그램2020-01-06

    2 trial sites

  • Phase 1UIC201903,UIC2019042019-12-17

    1 trial site

  • Bioequivalence유나잘탄정5/160밀리그램2019-12-10

    2 trial sites

  • Bioequivalence유나잘탄정5/80밀리그램2019-12-10

    2 trial sites

  • Bioequivalence힐러스메트정50/500밀리그램2019-10-14

    2 trial sites

  • Phase 1UI0302019-10-01

    2 trial sites

  • Bioequivalence힐러스정50밀리그램(빌다글립틴)2019-09-06

    2 trial sites

  • Bioequivalence프레펜틴정150밀리그램(프레가발린)2019-07-29

    2 trial sites

  • Phase 3UI0282019-04-29

    4 trial sites

  • Phase 1UI0282019-01-24

    2 trial sites

  • Phase 1UI0182018-11-15

    1 trial site

  • Phase 3UI022, UI0232018-11-07

    43 trial sites

  • Phase 1UI0372018-10-15

    1 trial site

  • Phase 1UI022, UI0232018-07-05

    1 trial site

  • Bioequivalence덱시마정2018-07-02

    2 trial sites

  • Phase 1UI0142018-05-25

    1 trial site

  • Phase 1UI0142018-05-24

    1 trial site

  • Bioequivalence오메가-3-산에틸에스테르90 2g2018-03-20

    2 trial sites

  • Bioequivalence오메가-3-산에틸에스테르90 1g2018-03-20

    2 trial sites

  • Phase 1UI0262017-07-17

    1 trial site

  • Phase 3UI0262017-07-13

    6 trial sites

  • Phase 1UI0142017-07-13

    1 trial site

  • Phase 3UI0182017-06-22

    22 trial sites

  • Phase 1UI0282017-05-12

    1 trial site

  • Phase 2UI0262017-04-26

    6 trial sites

  • Bioequivalence덱시마정2017-04-21

    2 trial sites

  • Bioequivalence글리세틸시럽(콜린알포세레이트)2017-03-31

    2 trial sites

  • Bioequivalence세페신정(세페타메트피복실염산염)(제제개선 후)2017-03-06

    2 trial sites

  • Phase 1UI022, UI0232017-02-27

    1 trial site

  • Bioequivalence페고트정80밀리그램(페북소스타트)2017-02-17

    2 trial sites

  • Bioequivalence티글러정(티카그렐러)2016-11-11

    2 trial sites

Showing the 80 most recent of 129 records.

AI reads

MAA server logs · IP-verified
0
Read to answer a question

Someone asked an AI a question, and it fetched this page live to answer.

2
Crawled for indexing

Collected for later use. Not a signal of interest.

0answer
index 2
Last 7 days
0answer
index 2
Last 30 days
0answer
index 2
All time
  • OpenAIOAI-SearchBot2

Measured since Aug 26, 2026 · 1 AI engines · last read Aug 26, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.

Connect this index to your AI tool →

Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies in the same categoryBiotech & Drug Discovery

AHNLAB,INC.100

KOSDAQ-listed integrated security company behind the V3 antivirus and AhnLab TrusGuard and XDR solutions.

ORGANOIDSCIENCES LTD.100

Organoid-based biotech founded 2018, KOSDAQ-listed 2025, developing the ATORM-C regenerative therapeutic and ODISEI evaluation solution.

CG Invites Co., Ltd.85

Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.

Eone Diagnomics Genome Center Co., Ltd.85

EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.

SK Chemicals Co., Ltd.85

A diversified SK group company operating eco-friendly chemical materials alongside pharmaceutical products like Joins and vaccines through subsidiary SK Bioscience.

ABION Inc.85

KOSDAQ-listed biotech developing biomarker-driven targeted cancer therapies including lead candidate Vabametkib (ABN401).

Y-Biologics, Inc85

KOSDAQ-listed antibody biotech developing the next-generation immuno-oncology candidate Multi-AbKine on its fully human antibody library Ymax®-ABL.

ProGen, Co,, LTD.85

KONEX-listed biotech venture developing new drug candidates with its multi-target fusion protein platform NTIG®

GI Innovation Inc.85

Biotech company developing fusion-protein immuno-oncology and allergy therapeutics, listed on KOSDAQ since 2023.

SillaJen, Inc.85

SillaJen, Inc., founded in 2006 and listed on KOSDAQ in 2016, develops the oncolytic virus immunotherapy Pexa-Vec.

SK Bioscience Co.,Ltd84

A vaccine specialist developing in-house products such as SKYCellflu and SKYZoster while also serving as CDMO for AstraZeneca and Novavax.

LigaChem Biosciences Inc.83

An ADC (antibody-drug conjugate) developer with its ConjuALL platform, having licensed pipeline assets to Janssen, Ono Pharmaceutical, and other global partners.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition